Peripheral blood lymphocytes P-glycoprotein (P-gp, gp-170) expression in allogenic kidney transplant patients

Nephrology

Volumn 11, Issue 3, 2006, Pages 257-260

  Kotrych, Katarzyna ^a   Masiuk, Marek ^a   Domański, Leszek ^a   Rózański, Jacek ^a   Droździk, Marek ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Allogenic transplant; Immunosuppression; P glycoprotein expression; Renal transplantation

Indexed keywords

AZATHIOPRINE; CD19 ANTIGEN; CD56 ANTIGEN; CYCLOSPORIN A; DILTIAZEM; GLYCOPROTEIN 170; GLYCOPROTEIN P; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; STEROID; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADULT; ALLOGRAFT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PERIPHERAL LYMPHOCYTE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TREATMENT DURATION;

ACUTE DISEASE; ADULT; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; P-GLYCOPROTEIN; PROGNOSIS; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 33744797955     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2006.00555.x     Document Type: Article

References (14)

1. Danovitch GM, ed. Handbook of Kidney Transplantation, 3th edn. Boston : Little, Brown and Co., 2000.
2. Lo A, Burcart GJ. P-glycoprotein and drug therapy in organ transplantation. J. Clin. Pharmacol. 1999 39 : 995 1005.
3. Lown KS, Mayo RR, Leichtman AB et al. Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine. Clin. Pharmacol. Ther. 1997 62 : 248 60.
4. Donnenberg VS, Griffin DL, Burcart GJ, Donnenberg AD. P-glycoprotein (P-gp) is responsible for drug elimination in peripheral T cells from solid organ and stem cell transplant recipients. XVII World Congress of Transplantation Society, Montreal, Canada, 1998.
5. Takeuchi H, Hirano T, Oka K et al. Lymphocyte sensitivity to cyclosporine and tacrolimus in chronic renal failure patients and clinical significance in renal transplantation. Transplant. Proc. 1998 30 : 36 9.
6. Fardel O, Lecureur V, Guillouzo A. Regulation by dexamethasone of P-glycoprotein expression in cultured rat hepatocytes. FEBS Lett. 1993 327 : 189 93.
7. Synold TW, Dussault I, Forman BM. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nat. Med. 2001 7 : 584 90.
8. The EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation (part 1). Nephrol. Dial. Transplant. 2000 15 Suppl. 7 1 85.
9. Meaden ER, Hoggard PG, Khoo SH, Back DJ. Determination of P-gp and MRP1 expression and function in peripheral blood mononuclear cells in vivo. J. Immunol. Methods 2002 262 : 159 65.
10. Parasrampuria DA, Marinne V, Lantz MV, Brinbaum JL, Vincenti FG, Benet LZ. Effect of calcineurin inhibitor therapy on P-gp expression and function in lymphocytes of renal transplant patients: A preliminary evaluation. J. Clin. Pharmacol. 2002 42 : 304 11.
11. Gotzl M, Wallner J, Gsur A et al. MDR1 gene expression in lymphocytes of patients with renal transplants. Nephron 1995 96 : 277 80.
12. Kemnitz J, Uysal A, Haverich A et al. Multidrug resistance in heart transplant patients: A preliminary communication on a possible mechanism of therapy-resistant rejection. J. Heart Lung Transplant. 1991 10 : 201 10.
13. Melk A, Daniel V, Weimer R et al. P-glycoprotein expression is not a useful predictor of acute or chronic kidney graft rejection. Transpl. Int. 1999 12 : 10 17.
14. Hirano T, Onda K, Toma T, Miyaoka M, Moriyasu F, Oka KZ. MDR1 mRNA expressions in peripheral blood mononuclear cells of patients with ulcerative colitis in relation to glucocorticoid administration. J. Clin. Pharmacol. 2004 44 : 481 6.